Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

0.5465
Delayed Data
As of Dec 07
 +0.0227 / +4.33%
Today’s Change
0.32
Today|||52-Week Range
4.66
-82.92%
Year-to-Date
No recent news for Northwest Biotherapeutics Inc.

Today’s Trading

Previous close0.52
Today’s open0.53
Day’s range0.51 - 0.59
Volume1,045,150
Average volume (3 months)2,018,059
Market cap$65.3M
Dividend yield--
Data as of 3:59pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)+35.37%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+19.60%
P/E ratioNM
Price/Sales143.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AFMDAffimed NV0.000.00%
EPIXESSA Pharma Inc-0.04-1.75%
ADMPAdamis Pharmaceutica...-0.10-3.39%
DRNADicerna Pharmaceutic...-0.02-0.66%
Data as of 3:59pm ET, 12/07/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$1.7M
Annual profit (last year)-$114.7M
Net profit margin-6,598.10%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO, CFO &
CAO
Linda F. Powers
Chief Scientific Officer &
Secretary
Alton L. Boynton
Corporate headquarters
Bethesda, Maryland

Forecasts


Search for Jobs